Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

NCT03561584 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Primary Sclerosing Cholangitis

Interventions

DRUG: Sulfasalazine
DRUG: Placebo

Sponsor

Brigham and Women's Hospital